Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early-stage Breast Cancer
Interventions: DRUG: Tamoxifen alone|DRUG: Tamoxifen + Aminoglutethimide
Sponsor: Austrian Breast & Colorectal Cancer Study Group
Collaborators: AstraZeneca